Endpoint Clinical acquires Bluefin, creating intelligence for every stage
of the clinical supply journey
Bluefin forecasts clinical supply in real time and operates independently of any RTSM, including Endpoint’s. Customers with Endpoint RTSM and Bluefin forecasting gain a single view from demand planning through trial supply delivery seamlessly.
Endpoint + Bluefin
Intelligence for Every Stage of
the Clinical Supply Journey
Reliable RTSM Solutions
- Proven RTSM leader at scale: 2,300+ studies, 1M+ patients, 100,000+ sites, 90+ countries
- 200+ years of combined leadership experience, backed by Pulse and next-generation Elosity, with embedded biostats, UAT, differentiated AI and delivery services
- Named a Leader in the 2025 Everest Group RTSM PEAK Matrix®, differentiated by AI-powered protocol analysis and supply intelligence
Real-Time Supply Forecasting
- Purpose-built clinical supply planning specialist: demand forecasting, inventory planning, and distribution strategy
- AI-driven forecasting and optimization that replaces manual processes, generating supply and distribution plans in minutes
- Modern, integration-first cloud platform with open APIs and real-time data synchronization
Result
Together, Endpoint and Bluefin address the full range of increasingly complex study designs, including adaptive trials, cohort-based studies, decentralized trials, and global multi-arm protocols. Bluefin’s forecasting works independently, or, when a sponsor or CRO chooses to connect it with Endpoint’s RTSM, brings intelligence to every stage of the clinical supply journey, from forecast to fulfillment. Either way, sponsors and CROs gain the scale, accuracy, and confidence needed to manage the demands of next-gen clinical development.
What This Means for Sponsors and CROs
01
Your RTSM stays your choice
Bluefin continues to operate independently of any RTSM vendor, including Endpoint’s. If your studies run on a different platform today, nothing about
that changes.
02
The same standards, now with scale
Bluefin’s security, quality, and implementation practices align with the enterprise standards Endpoint has applied across 2,300+ studies in 90+countries.
03
Faster answers when trials change
Protocol amendments, enrollment shifts, and new countries get modeled in minutes, not renegotiated across spreadsheets between sponsor and CRO teams.
What Bluefin Delivers
Speed, granularity, and flexibility built into every study, from day one.
Under 1 Hr
to forecast even complex titration or weight-based studies
Site & Dose Level
forecast granularity, powered by Bluefin’s Digital Twin architecture
Unlimited Scenerios
modeled in minutes, not days, for faster planning decisions
Self-Service
study setup, eliminating long onboarding cycles
Two ways to get started
Explore more about Bluefin or reach out with questions about what this means for you.